90-day Repeated-dose Oral Toxicity Study of 20 kGy Irradiated Cold Water Extract Powder of Mistletoe |
Kim, Jin-Kyung
(Dept. of Medical Life Science, Catholic University of Daegu)
Jeon, Young-Eun (Dept. of Food Science and Nutrition & The Korean Institute of Nutrition, Hallym University) Yin, Xing Fu (Dept. of Food Science and Nutrition & The Korean Institute of Nutrition, Hallym University) Lee, Ju-Woon (Division of Radiation Application Research, Korea Atomic Energy Research Institute) Kang, Il-Jun (Dept. of Food Science and Nutrition & The Korean Institute of Nutrition, Hallym University) |
1 | Bussing A. 1997. Mistletoe: a story with an open end. Anti-Cancer Drug 8(suppl 1): S1-S2. |
2 | Rentea R, Lyon E, Hunter R. 1981. Biologic properties of iscador: a Viscum album preparation: I. Hyperplasia of the thymic cortex and accelerated regeneration of hematopoietic cells following x-irradiation. Lab Invest 44: 43-48. |
3 | Walzel H, Mix E, Jenssen HL, Ziska P, Franz H. 1982. Estimation of toxicity of the mistletoe lectin 1 using the footpad swelling test in mice. Acta Histochem 71: 41-42. DOI ScienceOn |
4 | Stein GM, Pfuller U, Schietzel M, Bussing A. 2000. Toxic proteins from European mistletoe (Viscum album L.): increase of intracellular IL-4 but decrease of IFN-gamma in apoptotic cells. Anticancer Res 20: 1673-1678. |
5 | Gossrau R, Franz H. 1990. Histochemical response of mice to mistletoe lectin I (ML I). Histochemistry 94: 531-537. DOI |
6 | Wolford ST, Schroer RA, Gohs FX, Gallo PP, Brodec M, Falk HB, Ruhren FR. 1986. Reference range data base for serum chemistry and hematology values in laboratory animals. J Toxicol Environ Health 18: 161-188. DOI |
7 | Park CH, Park CG, Bang KH, Park HW, Seong NS. 2003. Plant growth and anatomical characteristics of Korean mistel (Viscum album var. coloratum (kom.) Ohwi). Korean J Med Crop Sci 11: 122-126. 과학기술학회마을 |
8 | Kuttan G, Kuttan R. 1992. Immunomodulatory activity of a peptide isolated from Viscum album extract (NSC 635 089). Immunol Invest 21: 285-296. DOI |
9 | Hajto T, Hostanska K, Frei K, Rordorf C, Gabius HJ. 1990. Increased secretion of tumor necrosis factor , interleukin 1, and interleukin 6 by human mononuclear cells exposed to -galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 50: 3322-3326. |
10 | Bussing A, Suzart K, Schweizer K. 1997. Differences in the apoptosis-inducing properties of Viscum album L. extracts. Anti-Cancer Drug 8(suppl 1): S9-S14. DOI |
11 | Habeck M. 2003. Mistletoe compound enters clinical trials. Drug Discov Today 8: 52-53. DOI |
12 | Bauer C, Oppel T, Rueff F, Przybilla B. 2005. Anaphylaxis to viscotoxins of mistletoe (Viscum album) extracts. Ann Allergy Asthma Immunol 94: 86-89. DOI |
13 | Lyu SY, Park SM, Choung BY, Park WB. 2000. Comparative study of Korean (Viscum album var. coloratum) and European mistletoes (Viscum album). Arch Pharm Res 23: 592-598. 과학기술학회마을 DOI |
14 | Jung MJ, Yoo YC, Lee KB, Kim JB, Song KS. 2004. Isolation of epi-oleanolic acid from Korean mistletoe and its apoptosis-inducing activity in tumor cells. Arch Pharm Res 27: 840-844. 과학기술학회마을 DOI |
15 | Khwaja TA, Dias CB, Pentecost S. 1986. Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids. Oncology 43(suppl 1): 42-50. DOI |